The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1 ) on Crohn's disease experimental model
Parasite Immunology · 2024
DOI: 10.1111/pim.13019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite Immunology, 2024. Verfasst von Hamid Hasanpour und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran. Hauptthemen laut MEDLINE: Colitis, Crohn Disease, Fasciola hepatica, Fascioliasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.
Abstract (Originalsprache)
The immunomodulatory potential of the excretory‐secretory (E/S) proteins of the helminths has been shown in previous investigations. This study evaluated the effects of the recombinants and excretory‐secretory proteins of the Fasciola hepatica on induced colitis in Balb/c mice. The F. hepatica Recombinant proteins, Cathepsin L1 and Peroxiredoxin, and E/S proteins were intraperitoneally injected into the three mice groups as the case groups, while the control groups received PBS. Colitis was induced in mice by intraluminal administration of the 2, 4, 6‐Trinitrobenzenesulfonic acid solution (TNBS). After 8 h, the case groups received the second dosage of the treatments, and it was repeated 24 h later. The immunological, pathological, and macroscopic changes were evaluated 3 days after colitis induction. The macroscopic evaluation revealed significantly lower inflammatory scores in the mice treated with recombinant Peroxiredoxin (rPRX) and recombinant Cathepsin L1 (rCL1). Despite the macroscopic observation, the pathological finding was insignificant between the groups. IFN‐γ secretion was significantly lower in splenocytes of the groups that received rPRX, rCL1, and E/S than the controls. IL‐10 showed significantly higher levels in groups treated with rPRX and rCL1 than controls, whereas the level of IL‐4 was not statistically significant. Excretory‐secretory proteins of the F. hepatica showed immunomodulatory potency and the main effects observed in this study were through the reduction of inflammatory cytokine and inflammation manifestation as well as induction of anti‐inflammatory cytokines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.
- Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
- Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Parasitology and Mycology, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden.
ORCID-Profile: Alireza Badirzadeh
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Hasanpour, H., Falak, R., Mokhtarian, K., Sadeghi, F., Masoumi, E., Asadollahi, P., Badirzadeh, A., Azami, S. J., Gholami, M. D., Pashangzadeh, S., Gharagozlou, M. J., Naserifar, R., & Mowlavi, G. (2024). The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1 ) on Crohn's disease experimental model. Parasite Immunology. https://doi.org/10.1111/pim.13019
Vancouver
Hasanpour H, Falak R, Mokhtarian K, Sadeghi F, Masoumi E, Asadollahi P, et al. The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1 ) on Crohn's disease experimental model. Parasite Immunology. 2024. doi:10.1111/pim.13019
BibTeX
@article{Hasanpour2024,
author = {Hasanpour, Hamid and Falak, Reza and Mokhtarian, Kobra and Sadeghi, Fatemeh and Masoumi, Elham and Asadollahi, Parisa and Badirzadeh, Alireza and Azami, Sanaz Jafarpour and Gholami, Mohammad Davoodzadeh and Pashangzadeh, Salar and Gharagozlou, Mohammad Javad and Naserifar, Razi and Mowlavi, Gholamreza},
title = {The effects of Fasciola hepatica recombinant proteins (peroxiredoxin and cathepsin L1 ) on Crohn's disease experimental model},
journal = {Parasite Immunology},
year = {2024},
doi = {10.1111/pim.13019}
}
EUVIMED